TSLA Tesla | $177.68 -1.2% | 3/28/2024 | Target Lowered by | Wedbush | - | Outperform -> Outperform | $315.00 -> $300.00 | N/A | View details for Wedbush rating of Tesla (NASDAQ:TSLA) on 3/28/2024 |
RH RH | $346.38 +16.6% | 3/28/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $275.00 -> $320.00 | N/A | View details for Wedbush rating of RH (NYSE:RH) on 3/28/2024 |
TRNO Terreno Realty | $65.96 +1.0% | 3/28/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $67.00 | N/A | View details for Wedbush rating of Terreno Realty (NYSE:TRNO) on 3/28/2024 |
GPRO GoPro | $2.31 +3.6% | 3/27/2024 | Reiterated by | Wedbush | Analyst A. Reese | Neutral | $2.00 | Low | View details for Wedbush rating of GoPro (NASDAQ:GPRO) on 3/27/2024 |
NVCR NovoCure | $15.52 +6.0% | 3/27/2024 | Reiterated by | Wedbush | - | Neutral | $21.00 | Low | View details for Wedbush rating of NovoCure (NASDAQ:NVCR) on 3/27/2024 |
STKS ONE Group Hospitality | $5.00 -1.4% | 3/27/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $5.00 | Low | View details for Wedbush rating of ONE Group Hospitality (NASDAQ:STKS) on 3/27/2024 |
|
NFLX Netflix | $606.82 -1.1% | 3/27/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $615.00 -> $725.00 | Low | View details for Wedbush rating of Netflix (NASDAQ:NFLX) on 3/27/2024 |
APRE Aprea Therapeutics | $6.16 +1.5% | 3/27/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $9.00 -> $11.00 | Low | View details for Wedbush rating of Aprea Therapeutics (NASDAQ:APRE) on 3/27/2024 |
NKE NIKE | $93.89 -0.3% | 3/27/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $115.00 | Low | View details for Wedbush rating of NIKE (NYSE:NKE) on 3/27/2024 |
GME GameStop | $12.86 -2.4% | 3/27/2024 | Target Lowered by | Wedbush | - | Underperform -> Underperform | $6.00 -> $5.60 | Low | View details for Wedbush rating of GameStop (NYSE:GME) on 3/27/2024 |
STOK Stoke Therapeutics | $13.40 -5.4% | 3/26/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $13.00 -> $17.00 | Low | View details for Wedbush rating of Stoke Therapeutics (NASDAQ:STOK) on 3/26/2024 |
STRO Sutro Biopharma | $5.69 +15.4% | 3/26/2024 | Target Lowered by | Wedbush | - | Outperform -> Outperform | $12.00 -> $8.00 | Low | View details for Wedbush rating of Sutro Biopharma (NASDAQ:STRO) on 3/26/2024 |
ATXS Astria Therapeutics | $14.32 +5.3% | 3/26/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $17.00 | Low | View details for Wedbush rating of Astria Therapeutics (NASDAQ:ATXS) on 3/26/2024 |
MSFT Microsoft | $421.11 -0.1% | 3/26/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $475.00 -> $500.00 | Low | View details for Wedbush rating of Microsoft (NASDAQ:MSFT) on 3/26/2024 |
WLDN Willdan Group | $28.96 -0.8% | 3/25/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $30.00 -> $35.00 | Low | View details for Wedbush rating of Willdan Group (NASDAQ:WLDN) on 3/25/2024 |
UMH UMH Properties | $16.04 +1.3% | 3/25/2024 | Reiterated by | Wedbush | Analyst R. Anderson | Neutral | $17.00 | Low | View details for Wedbush rating of UMH Properties (NYSE:UMH) on 3/25/2024 |
CMPX Compass Therapeutics | $1.99 -2.9% | 3/22/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $8.00 | Low | View details for Wedbush rating of Compass Therapeutics (NASDAQ:CMPX) on 3/22/2024 |
DNTH Dianthus Therapeutics | $30.53 -0.2% | 3/22/2024 | Target Raised by | Wedbush | Analyst L. Chico | Outperform -> Outperform | $24.00 -> $33.00 | Low | View details for Wedbush rating of Dianthus Therapeutics (NASDAQ:DNTH) on 3/22/2024 |
DRI Darden Restaurants | $167.62 +0.4% | 3/22/2024 | Target Lowered by | Wedbush | - | Outperform -> Outperform | $187.00 -> $181.00 | Low | View details for Wedbush rating of Darden Restaurants (NYSE:DRI) on 3/22/2024 |
MGPI MGP Ingredients | $86.34 +0.6% | 3/22/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $120.00 | Low | View details for Wedbush rating of MGP Ingredients (NASDAQ:MGPI) on 3/22/2024 |
ASO Academy Sports and Outdoors | $67.25 -1.0% | 3/22/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $80.00 | Low | View details for Wedbush rating of Academy Sports and Outdoors (NASDAQ:ASO) on 3/22/2024 |
RH RH | $346.38 +16.6% | 3/22/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $275.00 | Low | View details for Wedbush rating of RH (NYSE:RH) on 3/22/2024 |
GOOGL Alphabet | $150.54 -0.2% | 3/22/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $160.00 -> $175.00 | Low | View details for Wedbush rating of Alphabet (NASDAQ:GOOGL) on 3/22/2024 |
LULU Lululemon Athletica | $392.46 +0.8% | 3/22/2024 | Target Lowered by | Wedbush | - | Outperform -> Outperform | $548.00 -> $492.00 | Low | View details for Wedbush rating of Lululemon Athletica (NASDAQ:LULU) on 3/22/2024 |
CMG Chipotle Mexican Grill | $2,929.82 +0.2% | 3/22/2024 | Target Raised by | Wedbush | Analyst N. Setyan | Neutral -> Neutral | $2,400.00 -> $2,850.00 | Low | View details for Wedbush rating of Chipotle Mexican Grill (NYSE:CMG) on 3/22/2024 |
IRON Disc Medicine | $60.07 -0.7% | 3/21/2024 | Reiterated by | Wedbush | - | Outperform | $79.00 -> $84.00 | Low | View details for Wedbush rating of Disc Medicine (NASDAQ:IRON) on 3/21/2024 |
WSM Williams-Sonoma | $318.02 +1.3% | 3/21/2024 | Reiterated by | Wedbush | Analyst S. Basham | Outperform -> Outperform | $330.00 | Low | View details for Wedbush rating of Williams-Sonoma (NYSE:WSM) on 3/21/2024 |
GEO The GEO Group | $14.26 +0.4% | 3/21/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $15.00 | Low | View details for Wedbush rating of The GEO Group (NYSE:GEO) on 3/21/2024 |
CXW CoreCivic | $15.79 +0.9% | 3/21/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $18.00 | Low | View details for Wedbush rating of CoreCivic (NYSE:CXW) on 3/21/2024 |
MU Micron Technology | $118.36 -0.7% | 3/21/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $103.00 -> $130.00 | Low | View details for Wedbush rating of Micron Technology (NASDAQ:MU) on 3/21/2024 |
AAPL Apple | $170.80 -1.4% | 3/21/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $250.00 | Low | View details for Wedbush rating of Apple (NASDAQ:AAPL) on 3/21/2024 |
ALIT Alight | $9.85 +0.6% | 3/21/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $13.00 -> $14.00 | Low | View details for Wedbush rating of Alight (NYSE:ALIT) on 3/21/2024 |
TYRA Tyra Biosciences | $16.01 -1.8% | 3/21/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $28.00 | Low | View details for Wedbush rating of Tyra Biosciences (NASDAQ:TYRA) on 3/21/2024 |
KBH KB Home | $71.12 +2.2% | 3/21/2024 | Target Raised by | Wedbush | Analyst J. Mccanless | Neutral -> Neutral | $60.00 -> $64.00 | Low | View details for Wedbush rating of KB Home (NYSE:KBH) on 3/21/2024 |
VOR Vor Biopharma | $2.34 +5.9% | 3/21/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $11.00 | Low | View details for Wedbush rating of Vor Biopharma (NYSE:VOR) on 3/21/2024 |
CHWY Chewy | $15.76 +0.7% | 3/21/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $25.00 | Low | View details for Wedbush rating of Chewy (NYSE:CHWY) on 3/21/2024 |
VERA Vera Therapeutics | $43.33 -1.1% | 3/21/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $21.00 -> $34.00 | Low | View details for Wedbush rating of Vera Therapeutics (NASDAQ:VERA) on 3/21/2024 |
ACET Adicet Bio | $2.36 +1.3% | 3/20/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $5.00 | Low | View details for Wedbush rating of Adicet Bio (NASDAQ:ACET) on 3/20/2024 |
DSGN Design Therapeutics | $3.88 -0.8% | 3/20/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $5.00 | Low | View details for Wedbush rating of Design Therapeutics (NASDAQ:DSGN) on 3/20/2024 |
FUSN Fusion Pharmaceuticals | $21.31 +0.0% | 3/19/2024 | Downgraded by | Wedbush | Analyst D. Nierengarten | Outperform -> Neutral | $24.00 | N/A | View details for Wedbush rating of Fusion Pharmaceuticals (NASDAQ:FUSN) on 3/19/2024 |
Urgent: Protect Your Investments from a Chinese Invasion (Ad) An alarming new reality is unfolding across America.
The United States is bracing for the unthinkable - a potential Chinese invasion. Click here to get my exclusive report NOW >>> |
PHVS Pharvaris | $23.25 -1.1% | 3/19/2024 | Reiterated by | Wedbush | Analyst L. Chico | Outperform -> Outperform | $35.00 | Low | View details for Wedbush rating of Pharvaris (NASDAQ:PHVS) on 3/19/2024 |
BLUE bluebird bio | $1.37 +0.4% | 3/19/2024 | Target Lowered by | Wedbush | - | Neutral -> Neutral | $1.72 -> $1.68 | Low | View details for Wedbush rating of bluebird bio (NASDAQ:BLUE) on 3/19/2024 |
ALPN Alpine Immune Sciences | $38.79 +0.4% | 3/19/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $47.00 | Low | View details for Wedbush rating of Alpine Immune Sciences (NASDAQ:ALPN) on 3/19/2024 |
LEGH Legacy Housing | $21.25 +1.9% | 3/19/2024 | Target Lowered by | Wedbush | - | Outperform -> Outperform | $31.00 -> $25.00 | Low | View details for Wedbush rating of Legacy Housing (NASDAQ:LEGH) on 3/19/2024 |
NCMI National CineMedia | $5.10 +0.8% | 3/19/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $4.50 -> $5.50 | Low | View details for Wedbush rating of National CineMedia (NASDAQ:NCMI) on 3/19/2024 |
NVDA NVIDIA | $906.12 +0.4% | 3/19/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $1,000.00 | Low | View details for Wedbush rating of NVIDIA (NASDAQ:NVDA) on 3/19/2024 |
NKE NIKE | $93.89 -0.3% | 3/19/2024 | Target Lowered by | Wedbush | - | Outperform -> Outperform | $131.00 -> $115.00 | Low | View details for Wedbush rating of NIKE (NYSE:NKE) on 3/19/2024 |
LEN Lennar | $171.70 +1.9% | 3/18/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $130.00 -> $144.00 | Low | View details for Wedbush rating of Lennar (NYSE:LEN) on 3/18/2024 |
TNGX Tango Therapeutics | $7.97 +3.5% | 3/18/2024 | Reiterated by | Wedbush | - | Outperform | $18.00 | Low | View details for Wedbush rating of Tango Therapeutics (NASDAQ:TNGX) on 3/18/2024 |
LOGI Logitech International | $89.40 +1.1% | 3/18/2024 | Reiterated by | Wedbush | - | Neutral | $92.00 | Low | View details for Wedbush rating of Logitech International (NASDAQ:LOGI) on 3/18/2024 |
TSLA Tesla | $177.68 -1.2% | 3/13/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $315.00 | Low | View details for Wedbush rating of Tesla (NASDAQ:TSLA) on 3/13/2024 |
MLTX MoonLake Immunotherapeutics | $49.06 -2.3% | 3/13/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $92.00 | Low | View details for Wedbush rating of MoonLake Immunotherapeutics (NASDAQ:MLTX) on 3/13/2024 |
LBPH Longboard Pharmaceuticals | $21.20 +1.0% | 3/13/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $32.00 | Low | View details for Wedbush rating of Longboard Pharmaceuticals (NASDAQ:LBPH) on 3/13/2024 |
PRPL Purple Innovation | $1.72 +9.9% | 3/13/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $1.25 -> $2.25 | Low | View details for Wedbush rating of Purple Innovation (NASDAQ:PRPL) on 3/13/2024 |
BIRD Allbirds | $0.72 +8.9% | 3/13/2024 | Target Lowered by | Wedbush | - | Neutral -> Neutral | $1.00 -> $0.90 | Low | View details for Wedbush rating of Allbirds (NASDAQ:BIRD) on 3/13/2024 |
TPX Tempur Sealy International | $56.83 +1.1% | 3/13/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $60.00 -> $66.00 | Low | View details for Wedbush rating of Tempur Sealy International (NYSE:TPX) on 3/13/2024 |
INFY Infosys | $17.92 +0.7% | 3/13/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $22.00 | Low | View details for Wedbush rating of Infosys (NYSE:INFY) on 3/13/2024 |
DRI Darden Restaurants | $167.62 +0.4% | 3/15/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $177.00 -> $187.00 | Low | View details for Wedbush rating of Darden Restaurants (NYSE:DRI) on 3/15/2024 |
PGY Pagaya Technologies | $10.09 -1.8% | 3/15/2024 | Target Lowered by | Wedbush | - | Neutral -> Neutral | $18.00 -> $11.50 | Low | View details for Wedbush rating of Pagaya Technologies (NASDAQ:PGY) on 3/15/2024 |
GERN Geron | $3.30 -0.3% | 3/15/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $6.00 | Low | View details for Wedbush rating of Geron (NASDAQ:GERN) on 3/15/2024 |
DECK Deckers Outdoor | $945.37 +0.8% | 3/15/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $895.00 -> $1,000.00 | Low | View details for Wedbush rating of Deckers Outdoor (NYSE:DECK) on 3/15/2024 |
RMBL RumbleON | $6.58 +2.7% | 3/15/2024 | Target Lowered by | Wedbush | - | Outperform -> Outperform | $7.50 -> $7.00 | Low | View details for Wedbush rating of RumbleON (NASDAQ:RMBL) on 3/15/2024 |
DKS DICK'S Sporting Goods | $223.66 +0.5% | 3/15/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $160.00 -> $210.00 | Low | View details for Wedbush rating of DICK’S Sporting Goods (NYSE:DKS) on 3/15/2024 |
SKLZ Skillz | $6.77 +5.5% | 3/15/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $15.00 | Low | View details for Wedbush rating of Skillz (NYSE:SKLZ) on 3/15/2024 |
GETY Getty Images | $4.11 -3.5% | 3/15/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $7.70 | Low | View details for Wedbush rating of Getty Images (NYSE:GETY) on 3/15/2024 |
STKS ONE Group Hospitality | $5.00 -1.4% | 3/15/2024 | Target Lowered by | Wedbush | - | Neutral -> Neutral | $6.00 -> $5.00 | Low | View details for Wedbush rating of ONE Group Hospitality (NASDAQ:STKS) on 3/15/2024 |
NHI National Health Investors | $62.46 +1.0% | 3/18/2024 | Target Raised by | Wedbush | Analyst R. Anderson | Outperform -> Outperform | $64.00 -> $66.00 | Low | View details for Wedbush rating of National Health Investors (NYSE:NHI) on 3/18/2024 |
TSVT 2seventy bio | $5.50 +2.2% | 3/18/2024 | Reiterated by | Wedbush | Analyst D. Nierengarten | Neutral -> Neutral | $5.00 | Low | View details for Wedbush rating of 2seventy bio (NASDAQ:TSVT) on 3/18/2024 |
FENC Fennec Pharmaceuticals | $11.23 +1.3% | 3/18/2024 | Reiterated by | Wedbush | - | Outperform | $16.00 | Low | View details for Wedbush rating of Fennec Pharmaceuticals (NASDAQ:FENC) on 3/18/2024 |
HEAR Turtle Beach | $17.34 +0.6% | 3/14/2024 | Reiterated by | Wedbush | - | Outperform | $14.00 -> $19.00 | N/A | View details for Wedbush rating of Turtle Beach (NASDAQ:HEAR) on 3/14/2024 |
S SentinelOne | $23.21 +2.3% | 3/14/2024 | Target Raised by | Wedbush | - | Overweight -> Overweight | $28.00 -> $32.00 | Low | View details for Wedbush rating of SentinelOne (NYSE:S) on 3/14/2024 |
JACK Jack in the Box | $69.55 -1.3% | 3/14/2024 | Upgraded by | Wedbush | Analyst N. Setyan | Neutral -> Outperform | $79.00 -> $88.00 | Low | View details for Wedbush rating of Jack in the Box (NASDAQ:JACK) on 3/14/2024 |
CLSD Clearside Biomedical | $1.69 +1.1% | 3/13/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $5.00 -> $4.00 | Low | View details for Wedbush rating of Clearside Biomedical (NASDAQ:CLSD) on 3/13/2024 |
BDTX Black Diamond Therapeutics | $5.15 +5.1% | 3/13/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $10.00 | Low | View details for Wedbush rating of Black Diamond Therapeutics (NASDAQ:BDTX) on 3/13/2024 |
GEO The GEO Group | $14.26 +0.4% | 3/13/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $15.00 | Low | View details for Wedbush rating of The GEO Group (NYSE:GEO) on 3/13/2024 |
NCMI National CineMedia | $5.10 +0.8% | 3/12/2024 | Reiterated by | Wedbush | - | Neutral | $4.50 | Low | View details for Wedbush rating of National CineMedia (NASDAQ:NCMI) on 3/12/2024 |
INZY Inozyme Pharma | $7.39
| 3/12/2024 | Reiterated by | Wedbush | - | Outperform | $15.00 | Low | View details for Wedbush rating of Inozyme Pharma (NASDAQ:INZY) on 3/12/2024 |
IKNA Ikena Oncology | $1.41 +1.4% | 3/12/2024 | Reiterated by | Wedbush | - | Outperform | $8.00 | Low | View details for Wedbush rating of Ikena Oncology (NASDAQ:IKNA) on 3/12/2024 |
MU Micron Technology | $118.36 -0.7% | 3/12/2024 | Reiterated by | Wedbush | - | Outperform | $95.00 -> $103.00 | Low | View details for Wedbush rating of Micron Technology (NASDAQ:MU) on 3/12/2024 |
ANAB AnaptysBio | $21.16 -1.0% | 3/12/2024 | Upgraded by | Wedbush | Analyst D. Nierengarten | Neutral -> Outperform | $20.00 -> $34.00 | Low | View details for Wedbush rating of AnaptysBio (NASDAQ:ANAB) on 3/12/2024 |
JANX Janux Therapeutics | $37.94 +0.1% | 3/11/2024 | Reiterated by | Wedbush | - | Outperform | $53.00 | Low | View details for Wedbush rating of Janux Therapeutics (NASDAQ:JANX) on 3/11/2024 |
SPRY ARS Pharmaceuticals | $10.97 +10.1% | 3/11/2024 | Reiterated by | Wedbush | - | Outperform | $19.00 | Low | View details for Wedbush rating of ARS Pharmaceuticals (NASDAQ:SPRY) on 3/11/2024 |
PLTR Palantir Technologies | $23.54 -4.0% | 3/8/2024 | Reiterated by | Wedbush | - | Outperform | $30.00 -> $35.00 | Low | View details for Wedbush rating of Palantir Technologies (NYSE:PLTR) on 3/8/2024 |
PEPG PepGen | $14.05 -0.3% | 3/7/2024 | Target Lowered by | Wedbush | - | Outperform -> Outperform | $21.00 -> $20.00 | Low | View details for Wedbush rating of PepGen (NASDAQ:PEPG) on 3/7/2024 |
ELEV Elevation Oncology | $5.03 +0.4% | 3/7/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $5.00 -> $8.00 | Low | View details for Wedbush rating of Elevation Oncology (NASDAQ:ELEV) on 3/7/2024 |
GBIO Generation Bio | $4.15 +12.2% | 3/7/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $5.00 | Low | View details for Wedbush rating of Generation Bio (NASDAQ:GBIO) on 3/7/2024 |
WSM Williams-Sonoma | $318.02 +1.3% | 3/7/2024 | Target Raised by | Wedbush | Analyst S. Basham | Outperform -> Outperform | $230.00 -> $280.00 | Low | View details for Wedbush rating of Williams-Sonoma (NYSE:WSM) on 3/7/2024 |
NYCB New York Community Bancorp | $3.25 -2.7% | 3/7/2024 | Target Lowered by | Wedbush | Analyst D. Chiaverini | Underperform -> Underperform | $3.50 -> $3.00 | N/A | View details for Wedbush rating of New York Community Bancorp (NYSE:NYCB) on 3/7/2024 |
SOFI SoFi Technologies | $7.43 +1.0% | 3/6/2024 | Reiterated by | Wedbush | Analyst D. Chiaverini | Underperform -> Underperform | $3.00 | Low | View details for Wedbush rating of SoFi Technologies (NASDAQ:SOFI) on 3/6/2024 |
OCS Oculis | $11.78 -1.1% | 3/6/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $29.00 | Low | View details for Wedbush rating of Oculis (NASDAQ:OCS) on 3/6/2024 |
Urgent: Protect Your Investments from a Chinese Invasion (Ad) An alarming new reality is unfolding across America.
The United States is bracing for the unthinkable - a potential Chinese invasion. Click here to get my exclusive report NOW >>> |
GOSS Gossamer Bio | $1.21 +3.4% | 3/6/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $6.00 | Low | View details for Wedbush rating of Gossamer Bio (NASDAQ:GOSS) on 3/6/2024 |
HEAR Turtle Beach | $17.34 +0.6% | 3/6/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $14.00 | N/A | View details for Wedbush rating of Turtle Beach (NASDAQ:HEAR) on 3/6/2024 |
TCRX TScan Therapeutics | $8.00 -3.6% | 3/6/2024 | Reiterated by | Wedbush | - | Outperform | $9.00 -> $10.00 | Low | View details for Wedbush rating of TScan Therapeutics (NASDAQ:TCRX) on 3/6/2024 |
ITOS iTeos Therapeutics | $13.39 +1.7% | 3/6/2024 | Reiterated by | Wedbush | - | Outperform | $25.00 -> $18.00 | Low | View details for Wedbush rating of iTeos Therapeutics (NASDAQ:ITOS) on 3/6/2024 |
APGE Apogee Therapeutics | $68.83 +1.1% | 3/5/2024 | Reiterated by | Wedbush | - | Outperform | $40.00 -> $87.00 | Low | View details for Wedbush rating of Apogee Therapeutics (NASDAQ:APGE) on 3/5/2024 |
ATXS Astria Therapeutics | $14.32 +5.3% | 3/5/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $17.00 | Low | View details for Wedbush rating of Astria Therapeutics (NASDAQ:ATXS) on 3/5/2024 |
LEN Lennar | $171.70 +1.9% | 3/5/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $130.00 | Low | View details for Wedbush rating of Lennar (NYSE:LEN) on 3/5/2024 |
TDUP ThredUp | $1.98 +2.1% | 3/5/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $4.00 | Low | View details for Wedbush rating of ThredUp (NASDAQ:TDUP) on 3/5/2024 |
SFIX Stitch Fix | $2.59 +6.1% | 3/5/2024 | Target Lowered by | Wedbush | - | Neutral -> Neutral | $4.00 -> $3.00 | Low | View details for Wedbush rating of Stitch Fix (NASDAQ:SFIX) on 3/5/2024 |
CCS Century Communities | $96.71 +2.2% | 3/5/2024 | Reiterated by | Wedbush | Analyst J. Mccanless | Neutral -> Neutral | $92.00 | Low | View details for Wedbush rating of Century Communities (NYSE:CCS) on 3/5/2024 |
CRWD CrowdStrike | $325.35 +1.0% | 3/5/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $278.00 -> $350.00 | Low | View details for Wedbush rating of CrowdStrike (NASDAQ:CRWD) on 3/5/2024 |
MELI MercadoLibre | $1,518.49 -0.3% | 3/5/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $2,000.00 | Low | View details for Wedbush rating of MercadoLibre (NASDAQ:MELI) on 3/5/2024 |
SE SEA | $53.85 +0.5% | 3/5/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $45.00 -> $72.00 | Low | View details for Wedbush rating of SEA (NYSE:SE) on 3/5/2024 |
CELH Celsius | $83.26 -0.2% | 3/4/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $75.00 -> $90.00 | Low | View details for Wedbush rating of Celsius (NASDAQ:CELH) on 3/4/2024 |
FUBO fuboTV | $1.60 +2.6% | 3/4/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $5.00 | Low | View details for Wedbush rating of fuboTV (NYSE:FUBO) on 3/4/2024 |
IMAX IMAX | $16.16
| 3/4/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $22.00 | Low | View details for Wedbush rating of IMAX (NYSE:IMAX) on 3/4/2024 |
ZS Zscaler | $193.08 -0.2% | 3/1/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $250.00 -> $260.00 | Low | View details for Wedbush rating of Zscaler (NASDAQ:ZS) on 3/1/2024 |
SOUN SoundHound AI | $6.13 +3.4% | 3/1/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $5.00 -> $9.00 | Low | View details for Wedbush rating of SoundHound AI (NASDAQ:SOUN) on 3/1/2024 |
NYCB New York Community Bancorp | $3.25 -2.7% | 3/1/2024 | Target Lowered by | Wedbush | Analyst D. Chiaverini | Underperform -> Underperform | $5.00 -> $3.50 | Low | View details for Wedbush rating of New York Community Bancorp (NYSE:NYCB) on 3/1/2024 |
VRNA Verona Pharma | $16.47 -0.2% | 3/1/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $33.00 | Low | View details for Wedbush rating of Verona Pharma (NASDAQ:VRNA) on 3/1/2024 |
MLTX MoonLake Immunotherapeutics | $49.06 -2.3% | 3/1/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $92.00 | Low | View details for Wedbush rating of MoonLake Immunotherapeutics (NASDAQ:MLTX) on 3/1/2024 |
XENE Xenon Pharmaceuticals | $42.92 -0.2% | 3/1/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $46.00 -> $51.00 | Low | View details for Wedbush rating of Xenon Pharmaceuticals (NASDAQ:XENE) on 3/1/2024 |
ORIC ORIC Pharmaceuticals | $13.35 -0.9% | 3/1/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $12.00 -> $20.00 | Low | View details for Wedbush rating of ORIC Pharmaceuticals (NASDAQ:ORIC) on 3/1/2024 |
NUVB Nuvation Bio | $4.09 +3.0% | 3/1/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $5.00 | Low | View details for Wedbush rating of Nuvation Bio (NYSE:NUVB) on 3/1/2024 |
GRBK Green Brick Partners | $60.90 +1.9% | 3/1/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $45.00 | Low | View details for Wedbush rating of Green Brick Partners (NASDAQ:GRBK) on 3/1/2024 |
BBY Best Buy | $82.60 +0.9% | 3/1/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $75.00 -> $85.00 | Low | View details for Wedbush rating of Best Buy (NYSE:BBY) on 3/1/2024 |
NTAP NetApp | $105.10 -0.1% | 3/1/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $85.00 -> $100.00 | Low | View details for Wedbush rating of NetApp (NASDAQ:NTAP) on 3/1/2024 |
LSEA Landsea Homes | $14.63 +4.0% | 3/1/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $16.00 | Low | View details for Wedbush rating of Landsea Homes (NASDAQ:LSEA) on 3/1/2024 |
PZZA Papa John's International | $67.21 +1.4% | 3/1/2024 | Reiterated by | Wedbush | Analyst N. Setyan | Outperform -> Outperform | $87.00 | Low | View details for Wedbush rating of Papa John’s International (NASDAQ:PZZA) on 3/1/2024 |
PSTG Pure Storage | $52.70 +0.3% | 2/29/2024 | Reiterated by | Wedbush | - | Outperform | $50.00 | Low | View details for Wedbush rating of Pure Storage (NYSE:PSTG) on 2/29/2024 |
SRPT Sarepta Therapeutics | $130.68 +0.3% | 2/29/2024 | Reiterated by | Wedbush | - | Outperform | $224.00 | Low | View details for Wedbush rating of Sarepta Therapeutics (NASDAQ:SRPT) on 2/29/2024 |
KROS Keros Therapeutics | $65.51 +1.3% | 2/29/2024 | Reiterated by | Wedbush | - | Outperform | $86.00 | Low | View details for Wedbush rating of Keros Therapeutics (NASDAQ:KROS) on 2/29/2024 |
SBRA Sabra Health Care REIT | $14.87 +2.0% | 2/29/2024 | Reiterated by | Wedbush | - | Outperform | $17.00 | Low | View details for Wedbush rating of Sabra Health Care REIT (NASDAQ:SBRA) on 2/29/2024 |
CRM Salesforce | $301.21 -0.1% | 2/29/2024 | Target Raised by | Wedbush | - | Buy -> Buy | $280.00 -> $325.00 | Low | View details for Wedbush rating of Salesforce (NYSE:CRM) on 2/29/2024 |
AI C3.ai | $27.36 +0.4% | 2/29/2024 | Target Lowered by | Wedbush | - | Overweight -> Overweight | $42.00 -> $35.00 | Low | View details for Wedbush rating of C3.ai (NYSE:AI) on 2/29/2024 |
DIN Dine Brands Global | $47.04 +1.9% | 2/29/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $46.00 -> $48.00 | Low | View details for Wedbush rating of Dine Brands Global (NYSE:DIN) on 2/29/2024 |
MRSN Mersana Therapeutics | $4.54 +1.1% | 2/29/2024 | Upgraded by | Wedbush | Analyst D. Nierengarten | Neutral -> Outperform | $2.00 -> $7.00 | Low | View details for Wedbush rating of Mersana Therapeutics (NASDAQ:MRSN) on 2/29/2024 |
YOU Clear Secure | $21.48 +3.1% | 2/28/2024 | Reiterated by | Wedbush | - | Neutral | $23.00 | Low | View details for Wedbush rating of Clear Secure (NYSE:YOU) on 2/28/2024 |
GTHX G1 Therapeutics | $4.55 +1.8% | 2/28/2024 | Reiterated by | Wedbush | - | Outperform | $4.00 -> $5.00 | Low | View details for Wedbush rating of G1 Therapeutics (NASDAQ:GTHX) on 2/28/2024 |
KNSA Kiniksa Pharmaceuticals | $19.74 -1.3% | 2/28/2024 | Reiterated by | Wedbush | - | Outperform | $28.00 | Low | View details for Wedbush rating of Kiniksa Pharmaceuticals (NASDAQ:KNSA) on 2/28/2024 |
MNKD MannKind | $4.59 -0.9% | 2/28/2024 | Reiterated by | Wedbush | - | Outperform | $10.00 | Low | View details for Wedbush rating of MannKind (NASDAQ:MNKD) on 2/28/2024 |
RDFN Redfin | $6.79 +9.5% | 2/28/2024 | Reiterated by | Wedbush | - | Neutral | $8.00 | Low | View details for Wedbush rating of Redfin (NASDAQ:RDFN) on 2/28/2024 |
AAPL Apple | $170.80 -1.4% | 2/28/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $250.00 | Low | View details for Wedbush rating of Apple (NASDAQ:AAPL) on 2/28/2024 |
SNOW Snowflake | $163.11 +1.9% | 2/28/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $144.00 -> $210.00 | Low | View details for Wedbush rating of Snowflake (NYSE:SNOW) on 2/28/2024 |
APLS Apellis Pharmaceuticals | $57.79 -1.2% | 2/28/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $60.00 -> $67.00 | Low | View details for Wedbush rating of Apellis Pharmaceuticals (NASDAQ:APLS) on 2/28/2024 |
DNLI Denali Therapeutics | $20.44 -1.6% | 2/28/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $31.00 | Low | View details for Wedbush rating of Denali Therapeutics (NASDAQ:DNLI) on 2/28/2024 |
ARVN Arvinas | $41.64 +0.8% | 2/28/2024 | Target Raised by | Wedbush | Analyst R. Driscoll | Outperform -> Outperform | $33.00 -> $59.00 | Low | View details for Wedbush rating of Arvinas (NASDAQ:ARVN) on 2/28/2024 |
XNCR Xencor | $22.15 -1.2% | 2/28/2024 | Target Lowered by | Wedbush | - | Outperform -> Outperform | $36.00 -> $34.00 | Low | View details for Wedbush rating of Xencor (NASDAQ:XNCR) on 2/28/2024 |
ZNTL Zentalis Pharmaceuticals | $15.54 +2.3% | 2/28/2024 | Target Raised by | Wedbush | Analyst R. Driscoll | Neutral -> Neutral | $12.00 -> $15.00 | Low | View details for Wedbush rating of Zentalis Pharmaceuticals (NASDAQ:ZNTL) on 2/28/2024 |
RGNX REGENXBIO | $21.82 -1.6% | 2/28/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $21.00 | Low | View details for Wedbush rating of REGENXBIO (NASDAQ:RGNX) on 2/28/2024 |
Urgent: Protect Your Investments from a Chinese Invasion (Ad) An alarming new reality is unfolding across America.
The United States is bracing for the unthinkable - a potential Chinese invasion. Click here to get my exclusive report NOW >>> |
VRDN Viridian Therapeutics | $17.42 -0.5% | 2/28/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $39.00 -> $40.00 | Low | View details for Wedbush rating of Viridian Therapeutics (NASDAQ:VRDN) on 2/28/2024 |
KURA Kura Oncology | $21.57 +1.9% | 2/28/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $37.00 | Low | View details for Wedbush rating of Kura Oncology (NASDAQ:KURA) on 2/28/2024 |
RVLV Revolve Group | $20.94 +1.9% | 2/28/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $12.00 -> $17.00 | Low | View details for Wedbush rating of Revolve Group (NYSE:RVLV) on 2/28/2024 |
LOW Lowe's Companies | $253.35 +0.0% | 2/28/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $215.00 -> $250.00 | Low | View details for Wedbush rating of Lowe’s Companies (NYSE:LOW) on 2/28/2024 |
AZO AutoZone | $3,179.59 -0.4% | 2/28/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $2,950.00 -> $3,400.00 | Low | View details for Wedbush rating of AutoZone (NYSE:AZO) on 2/28/2024 |
NUVL Nuvalent | $75.00 -2.1% | 2/27/2024 | Reiterated by | Wedbush | - | Outperform | $99.00 | Low | View details for Wedbush rating of Nuvalent (NASDAQ:NUVL) on 2/27/2024 |
BEAM Beam Therapeutics | $34.01 +0.1% | 2/27/2024 | Reiterated by | Wedbush | - | Outperform | $48.00 -> $57.00 | Low | View details for Wedbush rating of Beam Therapeutics (NASDAQ:BEAM) on 2/27/2024 |
PLTK Playtika | $7.13 +2.0% | 2/27/2024 | Target Lowered by | Wedbush | - | Outperform -> Outperform | $14.75 -> $11.50 | Low | View details for Wedbush rating of Playtika (NASDAQ:PLTK) on 2/27/2024 |
ZM Zoom Video Communications | $66.73 +0.2% | 2/27/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $80.00 | Low | View details for Wedbush rating of Zoom Video Communications (NASDAQ:ZM) on 2/27/2024 |
U Unity Software | $27.30 +1.1% | 2/27/2024 | Target Lowered by | Wedbush | - | Outperform -> Outperform | $50.00 -> $33.50 | Low | View details for Wedbush rating of Unity Software (NYSE:U) on 2/27/2024 |
CAVA CAVA Group | $70.95 +2.6% | 2/27/2024 | Reiterated by | Wedbush | Analyst N. Setyan | Outperform -> Outperform | $59.00 -> $65.00 | Low | View details for Wedbush rating of CAVA Group (NYSE:CAVA) on 2/27/2024 |
FATE Fate Therapeutics | $7.46 +1.6% | 2/27/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $3.00 -> $7.00 | Low | View details for Wedbush rating of Fate Therapeutics (NASDAQ:FATE) on 2/27/2024 |
RVMD Revolution Medicines | $31.84 +0.4% | 2/27/2024 | Target Raised by | Wedbush | Analyst R. Driscoll | Outperform -> Outperform | $41.00 -> $42.00 | Low | View details for Wedbush rating of Revolution Medicines (NASDAQ:RVMD) on 2/27/2024 |
JANX Janux Therapeutics | $37.94 +0.1% | 2/27/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $24.00 -> $53.00 | Low | View details for Wedbush rating of Janux Therapeutics (NASDAQ:JANX) on 2/27/2024 |
CELH Celsius | $83.26 -0.2% | 2/27/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $75.00 -> $90.00 | Low | View details for Wedbush rating of Celsius (NASDAQ:CELH) on 2/27/2024 |
DPZ Domino's Pizza | $495.95 +0.8% | 2/26/2024 | Reiterated by | Wedbush | - | Outperform | $445.00 -> $520.00 | Low | View details for Wedbush rating of Domino’s Pizza (NYSE:DPZ) on 2/26/2024 |
TCRX TScan Therapeutics | $8.00 -3.6% | 2/26/2024 | Reiterated by | Wedbush | - | Outperform | $9.00 | Low | View details for Wedbush rating of TScan Therapeutics (NASDAQ:TCRX) on 2/26/2024 |
RITM Rithm Capital | $11.17 +0.9% | 2/26/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $13.00 | Low | View details for Wedbush rating of Rithm Capital (NYSE:RITM) on 2/26/2024 |
SWTX SpringWorks Therapeutics | $51.76 +3.3% | 2/26/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $60.00 -> $70.00 | Low | View details for Wedbush rating of SpringWorks Therapeutics (NASDAQ:SWTX) on 2/26/2024 |
KDP Keurig Dr Pepper | $30.81 +0.7% | 2/26/2024 | Target Lowered by | Wedbush | - | Outperform -> Outperform | $37.00 -> $35.00 | Low | View details for Wedbush rating of Keurig Dr Pepper (NASDAQ:KDP) on 2/26/2024 |
NHI National Health Investors | $62.46 +1.0% | 2/26/2024 | Upgraded by | Wedbush | Analyst R. Anderson | Neutral -> Outperform | $57.00 -> $64.00 | Low | View details for Wedbush rating of National Health Investors (NYSE:NHI) on 2/26/2024 |
AMC AMC Entertainment | $3.80 -12.4% | 2/23/2024 | Reiterated by | Wedbush | Analyst A. Reese | Neutral -> Neutral | $6.00 | Low | View details for Wedbush rating of AMC Entertainment (NYSE:AMC) on 2/23/2024 |
SNBR Sleep Number | $15.86 +1.0% | 2/23/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $12.00 -> $13.50 | Low | View details for Wedbush rating of Sleep Number (NASDAQ:SNBR) on 2/23/2024 |
W Wayfair | $69.19 +2.4% | 2/23/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $70.00 | Low | View details for Wedbush rating of Wayfair (NYSE:W) on 2/23/2024 |
FND Floor & Decor | $129.33 -0.2% | 2/23/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $115.00 -> $125.00 | Low | View details for Wedbush rating of Floor & Decor (NYSE:FND) on 2/23/2024 |
AXTI AXT | $4.82 -1.4% | 2/23/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $6.00 | Low | View details for Wedbush rating of AXT (NASDAQ:AXTI) on 2/23/2024 |
PRGS Progress Software | $53.16 +1.0% | 2/23/2024 | Target Raised by | Wedbush | Analyst D. Ives | Outperform -> Outperform | $65.00 -> $67.00 | Low | View details for Wedbush rating of Progress Software (NASDAQ:PRGS) on 2/23/2024 |
BKNG Booking | $3,658.13 -0.4% | 2/23/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $3,850.00 | Low | View details for Wedbush rating of Booking (NASDAQ:BKNG) on 2/23/2024 |
MELI MercadoLibre | $1,518.49 -0.3% | 2/23/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $1,800.00 -> $2,000.00 | Low | View details for Wedbush rating of MercadoLibre (NASDAQ:MELI) on 2/23/2024 |
IMAX IMAX | $16.16
| 2/23/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $22.00 | Low | View details for Wedbush rating of IMAX (NYSE:IMAX) on 2/23/2024 |
ZD Ziff Davis | $63.36 +0.4% | 2/23/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $75.00 -> $78.00 | Low | View details for Wedbush rating of Ziff Davis (NASDAQ:ZD) on 2/23/2024 |
NICE NICE | $260.54 +1.9% | 2/23/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $230.00 -> $270.00 | Low | View details for Wedbush rating of NICE (NASDAQ:NICE) on 2/23/2024 |
COGT Cogent Biosciences | $6.47 -0.8% | 2/23/2024 | Target Raised by | Wedbush | Analyst D. Nierengarten | Neutral -> Neutral | $5.00 -> $10.00 | Low | View details for Wedbush rating of Cogent Biosciences (NASDAQ:COGT) on 2/23/2024 |
CRI Carter's | $84.86 +2.1% | 2/23/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $67.00 -> $78.00 | Low | View details for Wedbush rating of Carter’s (NYSE:CRI) on 2/23/2024 |
CHUY Chuy's | $34.02 +0.3% | 2/23/2024 | Target Lowered by | Wedbush | - | Outperform -> Outperform | $41.00 -> $38.00 | Low | View details for Wedbush rating of Chuy’s (NASDAQ:CHUY) on 2/23/2024 |
RKT Rocket Companies | $14.77 +1.4% | 2/23/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $13.00 | Low | View details for Wedbush rating of Rocket Companies (NYSE:RKT) on 2/23/2024 |
ARDX Ardelyx | $7.50 +1.2% | 2/23/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $13.00 | Low | View details for Wedbush rating of Ardelyx (NASDAQ:ARDX) on 2/23/2024 |
ALIT Alight | $9.85 +0.6% | 2/22/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $13.00 | Low | View details for Wedbush rating of Alight (NYSE:ALIT) on 2/22/2024 |
EPAM EPAM Systems | $274.29 -0.8% | 2/22/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $320.00 -> $340.00 | Low | View details for Wedbush rating of EPAM Systems (NYSE:EPAM) on 2/22/2024 |
UTHR United Therapeutics | $240.80 -1.0% | 2/22/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $308.00 | Low | View details for Wedbush rating of United Therapeutics (NASDAQ:UTHR) on 2/22/2024 |
RCUS Arcus Biosciences | $18.74 +2.9% | 2/22/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $30.00 | Low | View details for Wedbush rating of Arcus Biosciences (NYSE:RCUS) on 2/22/2024 |
UFPI UFP Industries | $122.78 +0.8% | 2/22/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $102.00 | Low | View details for Wedbush rating of UFP Industries (NASDAQ:UFPI) on 2/22/2024 |
NVDA NVIDIA | $906.12 +0.4% | 2/22/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $800.00 -> $850.00 | Low | View details for Wedbush rating of NVIDIA (NASDAQ:NVDA) on 2/22/2024 |
ETSY Etsy | $69.46 +2.2% | 2/22/2024 | Target Lowered by | Wedbush | - | Neutral -> Neutral | $85.00 -> $80.00 | Low | View details for Wedbush rating of Etsy (NASDAQ:ETSY) on 2/22/2024 |
MTTR Matterport | $2.29 +17.5% | 2/22/2024 | Target Lowered by | Wedbush | - | Neutral -> Neutral | $5.00 -> $4.00 | Low | View details for Wedbush rating of Matterport (NASDAQ:MTTR) on 2/22/2024 |
WING Wingstop | $368.01 +0.6% | 2/22/2024 | Target Raised by | Wedbush | Analyst N. Setyan | Outperform -> Outperform | $330.00 -> $340.00 | Low | View details for Wedbush rating of Wingstop (NASDAQ:WING) on 2/22/2024 |
BROS Dutch Bros | $32.69 -1.4% | 2/22/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $37.00 | Low | View details for Wedbush rating of Dutch Bros (NYSE:BROS) on 2/22/2024 |
JACK Jack in the Box | $69.55 -1.3% | 2/22/2024 | Target Lowered by | Wedbush | - | Neutral -> Neutral | $83.00 -> $79.00 | Low | View details for Wedbush rating of Jack in the Box (NASDAQ:JACK) on 2/22/2024 |
CAKE Cheesecake Factory | $36.29 -0.2% | 2/22/2024 | Reiterated by | Wedbush | Analyst N. Setyan | Outperform -> Outperform | $40.00 | Low | View details for Wedbush rating of Cheesecake Factory (NASDAQ:CAKE) on 2/22/2024 |
SPRY ARS Pharmaceuticals | $10.97 +10.1% | 2/21/2024 | Reiterated by | Wedbush | - | Outperform | $19.00 | Low | View details for Wedbush rating of ARS Pharmaceuticals (NASDAQ:SPRY) on 2/21/2024 |
Urgent: Protect Your Investments from a Chinese Invasion (Ad) An alarming new reality is unfolding across America.
The United States is bracing for the unthinkable - a potential Chinese invasion. Click here to get my exclusive report NOW >>> |
TOL Toll Brothers | $129.49 +1.6% | 2/21/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $87.00 | Low | View details for Wedbush rating of Toll Brothers (NYSE:TOL) on 2/21/2024 |
HD Home Depot | $381.24 -1.2% | 2/21/2024 | Reiterated by | Wedbush | Analyst S. Basham | Outperform -> Outperform | $380.00 | Low | View details for Wedbush rating of Home Depot (NYSE:HD) on 2/21/2024 |
FUBO fuboTV | $1.60 +2.6% | 2/21/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $5.00 | Low | View details for Wedbush rating of fuboTV (NYSE:FUBO) on 2/21/2024 |
PLTK Playtika | $7.13 +2.0% | 2/21/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $14.75 | Low | View details for Wedbush rating of Playtika (NASDAQ:PLTK) on 2/21/2024 |
BYON Beyond | $36.10 +0.2% | 2/21/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $33.00 -> $35.00 | Low | View details for Wedbush rating of Beyond (NYSE:BYON) on 2/21/2024 |
LGIH LGI Homes | $115.97 +1.5% | 2/21/2024 | Target Lowered by | Wedbush | - | Neutral -> Neutral | $97.00 -> $88.00 | Low | View details for Wedbush rating of LGI Homes (NASDAQ:LGIH) on 2/21/2024 |
AZO AutoZone | $3,179.59 -0.4% | 2/20/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $2,950.00 | Low | View details for Wedbush rating of AutoZone (NYSE:AZO) on 2/20/2024 |
CVNA Carvana | $89.00 -1.5% | 2/20/2024 | Target Raised by | Wedbush | Analyst S. Basham | Neutral -> Neutral | $40.00 -> $50.00 | Low | View details for Wedbush rating of Carvana (NYSE:CVNA) on 2/20/2024 |
SRPT Sarepta Therapeutics | $130.68 +0.3% | 2/20/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $224.00 | Low | View details for Wedbush rating of Sarepta Therapeutics (NASDAQ:SRPT) on 2/20/2024 |
SQ Block | $84.49 +1.6% | 2/20/2024 | Reiterated by | Wedbush | Analyst M. Katri | Outperform -> Outperform | $90.00 | Low | View details for Wedbush rating of Block (NYSE:SQ) on 2/20/2024 |
AIP Arteris | $7.48 -0.3% | 2/20/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $17.00 | Low | View details for Wedbush rating of Arteris (NASDAQ:AIP) on 2/20/2024 |
ABR Arbor Realty Trust | $13.27 -0.9% | 2/20/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $17.00 | Low | View details for Wedbush rating of Arbor Realty Trust (NYSE:ABR) on 2/20/2024 |
TPH Tri Pointe Homes | $38.76 +2.2% | 2/20/2024 | Reiterated by | Wedbush | Analyst J. Mccanless | Neutral -> Neutral | $32.00 | Low | View details for Wedbush rating of Tri Pointe Homes (NYSE:TPH) on 2/20/2024 |
DOOR Masonite International | $131.48 +0.2% | 2/20/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $133.00 | Low | View details for Wedbush rating of Masonite International (NYSE:DOOR) on 2/20/2024 |
HR Healthcare Realty Trust | $14.25 +2.2% | 2/20/2024 | Downgraded by | Wedbush | Analyst R. Anderson | Outperform -> Neutral | $19.00 -> $15.00 | Low | View details for Wedbush rating of Healthcare Realty Trust (NYSE:HR) on 2/20/2024 |
HPP Hudson Pacific Properties | $6.42 +0.5% | 2/20/2024 | Downgraded by | Wedbush | Analyst R. Anderson | Outperform -> Neutral | $11.00 -> $7.50 | Low | View details for Wedbush rating of Hudson Pacific Properties (NYSE:HPP) on 2/20/2024 |
COIN Coinbase Global | $268.43 +4.6% | 2/16/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $180.00 -> $200.00 | Low | View details for Wedbush rating of Coinbase Global (NASDAQ:COIN) on 2/16/2024 |
DASH DoorDash | $138.91 +0.0% | 2/16/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $92.00 -> $115.00 | Low | View details for Wedbush rating of DoorDash (NASDAQ:DASH) on 2/16/2024 |
PANW Palo Alto Networks | $284.42 +0.8% | 2/16/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $350.00 -> $425.00 | Low | View details for Wedbush rating of Palo Alto Networks (NASDAQ:PANW) on 2/16/2024 |
INTC Intel | $44.41 +1.5% | 2/16/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $40.00 | Low | View details for Wedbush rating of Intel (NASDAQ:INTC) on 2/16/2024 |
W Wayfair | $69.19 +2.4% | 2/16/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $70.00 | Low | View details for Wedbush rating of Wayfair (NYSE:W) on 2/16/2024 |
ROKU Roku | $65.89 +0.5% | 2/16/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $120.00 | Low | View details for Wedbush rating of Roku (NASDAQ:ROKU) on 2/16/2024 |
RNG RingCentral | $35.10 +0.6% | 2/16/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $40.00 | Low | View details for Wedbush rating of RingCentral (NYSE:RNG) on 2/16/2024 |
GLOB Globant | $204.34 -0.2% | 2/16/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $250.00 | Low | View details for Wedbush rating of Globant (NYSE:GLOB) on 2/16/2024 |
GPC Genuine Parts | $155.57 +0.2% | 2/16/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $140.00 | Low | View details for Wedbush rating of Genuine Parts (NYSE:GPC) on 2/16/2024 |
RARE Ultragenyx Pharmaceutical | $46.43 -0.8% | 2/16/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $47.00 -> $48.00 | Low | View details for Wedbush rating of Ultragenyx Pharmaceutical (NASDAQ:RARE) on 2/16/2024 |
TVTX Travere Therapeutics | $7.62 -0.7% | 2/16/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $13.00 | Low | View details for Wedbush rating of Travere Therapeutics (NASDAQ:TVTX) on 2/16/2024 |
WD Walker & Dunlop | $101.04 +0.2% | 2/16/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $130.00 | Low | View details for Wedbush rating of Walker & Dunlop (NYSE:WD) on 2/16/2024 |
NVDA NVIDIA | $906.12 +0.4% | 2/16/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $800.00 -> $850.00 | Low | View details for Wedbush rating of NVIDIA (NASDAQ:NVDA) on 2/16/2024 |
KMX CarMax | $87.17 +0.2% | 2/16/2024 | Reiterated by | Wedbush | Analyst S. Basham | Outperform -> Outperform | $90.00 | Low | View details for Wedbush rating of CarMax (NYSE:KMX) on 2/16/2024 |
FND Floor & Decor | $129.33 -0.2% | 2/16/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $85.00 -> $115.00 | Low | View details for Wedbush rating of Floor & Decor (NYSE:FND) on 2/16/2024 |
BJRI BJ's Restaurants | $36.67 +2.6% | 2/16/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $40.00 | Low | View details for Wedbush rating of BJ’s Restaurants (NASDAQ:BJRI) on 2/16/2024 |
TXRH Texas Roadhouse | $154.19 -0.1% | 2/16/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $145.00 -> $160.00 | Low | View details for Wedbush rating of Texas Roadhouse (NASDAQ:TXRH) on 2/16/2024 |
WEN Wendy's | $18.87 -0.2% | 2/16/2024 | Target Lowered by | Wedbush | Analyst N. Setyan | Neutral -> Neutral | $20.00 -> $19.00 | Low | View details for Wedbush rating of Wendy’s (NASDAQ:WEN) on 2/16/2024 |
NTLA Intellia Therapeutics | $26.89 -0.5% | 2/15/2024 | Reiterated by | Wedbush | - | Neutral | $29.00 | Low | View details for Wedbush rating of Intellia Therapeutics (NASDAQ:NTLA) on 2/15/2024 |
GEO The GEO Group | $14.26 +0.4% | 2/15/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $14.00 | Low | View details for Wedbush rating of The GEO Group (NYSE:GEO) on 2/15/2024 |
MGPI MGP Ingredients | $86.34 +0.6% | 2/15/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $135.00 | Low | View details for Wedbush rating of MGP Ingredients (NASDAQ:MGPI) on 2/15/2024 |
APP AppLovin | $69.85 +1.4% | 2/15/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $58.50 -> $67.00 | Low | View details for Wedbush rating of AppLovin (NASDAQ:APP) on 2/15/2024 |
PEGA Pegasystems | $65.34 +0.4% | 2/15/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $58.00 | Low | View details for Wedbush rating of Pegasystems (NASDAQ:PEGA) on 2/15/2024 |
TRIP Tripadvisor | $27.67 -0.6% | 2/15/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $20.00 | Low | View details for Wedbush rating of Tripadvisor (NASDAQ:TRIP) on 2/15/2024 |
GLUE Monte Rosa Therapeutics | $6.98 -0.9% | 2/15/2024 | Initiated by | Wedbush | - | Outperform | $11.00 | Low | View details for Wedbush rating of Monte Rosa Therapeutics (NASDAQ:GLUE) on 2/15/2024 |
CGEM Cullinan Oncology | $17.65 -0.5% | 2/15/2024 | Initiated by | Wedbush | - | Outperform | $30.00 | Low | View details for Wedbush rating of Cullinan Oncology (NASDAQ:CGEM) on 2/15/2024 |
WING Wingstop | $368.01 +0.6% | 2/14/2024 | Target Raised by | Wedbush | Analyst N. Setyan | Outperform -> Outperform | $280.00 -> $330.00 | Low | View details for Wedbush rating of Wingstop (NASDAQ:WING) on 2/14/2024 |
SHAK Shake Shack | $107.66 +3.2% | 2/14/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $80.00 | Low | View details for Wedbush rating of Shake Shack (NYSE:SHAK) on 2/14/2024 |
BYON Beyond | $36.10 +0.2% | 2/14/2024 | Reiterated by | Wedbush | - | Outperform | $33.00 | Low | View details for Wedbush rating of Beyond (NYSE:BYON) on 2/14/2024 |
LYFT Lyft | $19.33 -0.8% | 2/14/2024 | Reiterated by | Wedbush | - | Neutral | $14.00 -> $15.00 | Low | View details for Wedbush rating of Lyft (NASDAQ:LYFT) on 2/14/2024 |
ABNB Airbnb | $166.01 -0.2% | 2/14/2024 | Reiterated by | Wedbush | - | Neutral | $150.00 -> $160.00 | Low | View details for Wedbush rating of Airbnb (NASDAQ:ABNB) on 2/14/2024 |
DENN Denny's | $9.16 +1.1% | 2/14/2024 | Target Lowered by | Wedbush | - | Neutral -> Neutral | $11.00 -> $10.50 | Low | View details for Wedbush rating of Denny’s (NASDAQ:DENN) on 2/14/2024 |
SHOP Shopify | $78.64 +0.0% | 2/13/2024 | Reiterated by | Wedbush | Analyst S. Devitt | Neutral | $68.00 | Low | View details for Wedbush rating of Shopify (NYSE:SHOP) on 2/13/2024 |
GTHX G1 Therapeutics | $4.55 +1.8% | 2/13/2024 | Target Lowered by | Wedbush | - | Outperform -> Outperform | $5.00 -> $4.00 | Low | View details for Wedbush rating of G1 Therapeutics (NASDAQ:GTHX) on 2/13/2024 |
CNK Cinemark | $17.89 -1.0% | 2/13/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $20.00 | Low | View details for Wedbush rating of Cinemark (NYSE:CNK) on 2/13/2024 |
YMAB Y-mAbs Therapeutics | $16.16 -2.1% | 2/12/2024 | Reiterated by | Wedbush | - | Outperform | $12.00 -> $18.00 | Low | View details for Wedbush rating of Y-mAbs Therapeutics (NASDAQ:YMAB) on 2/12/2024 |
CMRX Chimerix | $1.05 +4.0% | 2/12/2024 | Reiterated by | Wedbush | - | Outperform | $6.00 | Low | View details for Wedbush rating of Chimerix (NASDAQ:CMRX) on 2/12/2024 |
NUVL Nuvalent | $75.00 -2.1% | 2/12/2024 | Reiterated by | Wedbush | - | Outperform | $82.00 -> $99.00 | Low | View details for Wedbush rating of Nuvalent (NASDAQ:NUVL) on 2/12/2024 |
BIIB Biogen | $215.48 -0.4% | 2/12/2024 | Target Raised by | Wedbush | - | Neutral -> Neutral | $239.00 -> $245.00 | Low | View details for Wedbush rating of Biogen (NASDAQ:BIIB) on 2/12/2024 |
COOP Mr. Cooper Group | $78.02 +0.0% | 2/12/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $80.00 -> $85.00 | Low | View details for Wedbush rating of Mr. Cooper Group (NASDAQ:COOP) on 2/12/2024 |
RGNX REGENXBIO | $21.82 -1.6% | 2/12/2024 | Reiterated by | Wedbush | - | Neutral -> Neutral | $21.00 | Low | View details for Wedbush rating of REGENXBIO (NASDAQ:RGNX) on 2/12/2024 |
BLDR Builders FirstSource | $210.39 +0.3% | 2/12/2024 | Target Raised by | Wedbush | - | Outperform -> Outperform | $175.00 -> $225.00 | Low | View details for Wedbush rating of Builders FirstSource (NYSE:BLDR) on 2/12/2024 |
DBD Diebold Nixdorf | $34.44 -0.1% | 2/12/2024 | Reiterated by | Wedbush | Analyst M. Bryson | Neutral -> Neutral | $25.00 | Low | View details for Wedbush rating of Diebold Nixdorf (NYSE:DBD) on 2/12/2024 |
AAPL Apple | $170.80 -1.4% | 2/12/2024 | Reiterated by | Wedbush | - | Outperform -> Outperform | $250.00 | Low | View details for Wedbush rating of Apple (NASDAQ:AAPL) on 2/12/2024 |